Literature DB >> 24075664

Impact of bisphosphonate drug burden in alveolar bone during orthodontic tooth movement in a rat model: a pilot study.

Neelambar R Kaipatur1, Yuchin Wu, Samer Adeeb, Thomas R Stevenson, Paul W Major, Michael R Doschak.   

Abstract

INTRODUCTION: The aim of this pilot study was to investigate the effect of long-term bisphosphonate drug use (bone burden) on orthodontic tooth movement in a rat model.
METHODS: Sprague Dawley rats were used for orthodontic protraction of the maxillary first molars with nickel-titanium coil springs and temporary anchorage devices as anchorage. Four groups of 5 rats each were included in the study; the first 2 groups were dosed with alendronate or a vehicle during concurrent orthodontic tooth movement. The third and fourth groups were pretreated for 3 months with alendronate or vehicle injections, and bisphosphonate drug treatment was discontinued before orthodontic tooth movement. Tooth movement measurements were obtained at 0, 4, and 8 weeks using high-resolution in-vivo microcomputed tomography, and the tissues were analyzed with histology and dynamic labeling of bone turnover.
RESULTS: Appreciable tooth movement was achieved during the 8-week duration of this study with nickel-titanium coil springs and temporary anchorage devices. Both bisphosphonate treatment groups exhibited reduced tooth movement compared with the vehicle-dosed controls with a tendency toward more severe reduction in the bisphosphonate predosed group. Concurrent dosing of the bisphosphonate drug resulted in 56% and 65% reductions in tooth protraction at the 4-week and 8-week times, respectively. The impact of bisphosphonate bone burden in retarding tooth movement was even greater, with 77% and 86% reductions in tooth movement at 4 and 8 weeks, respectively.
CONCLUSIONS: In this study, we used a robust rat model of orthodontic tooth movement with temporary anchorage devices. It has provided evidence that the bone burden of previous bisphosphonate use will significantly inhibit orthodontic tooth movement.
Copyright © 2013 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24075664     DOI: 10.1016/j.ajodo.2013.06.015

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  6 in total

1.  Utility of injectable bisphosphonates in enhancing orthodontic retention in a goat model: A split-mouth study.

Authors:  Hana A Tokhtah; Adel M Alhadlaq
Journal:  Saudi Dent J       Date:  2022-03-30

2.  Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.

Authors:  Collin Jacobs; Christian Walter; Thomas Ziebart; Isabelle Dirks; Sabrina Schramm; Sarah Grimm; Elena Krieger; Heinrich Wehrbein
Journal:  Clin Oral Investig       Date:  2014-07-25       Impact factor: 3.573

Review 3.  Effect of local administration of bisphosphonate on orthodontic anchorage - A systematic review of animal studies.

Authors:  Sruthi Harikrishnan; Navaneethan Ramasamy
Journal:  J Orthod Sci       Date:  2022-08-24

Review 4.  Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review.

Authors:  Felipe José Fernández-González; Aránzazu Cañigral; Felipe Balbontín-Ayala; José Manuel Gonzalo-Orden; Felix de Carlos; Teresa Cobo; Jose Pedro Fernández-Vázquez; Fernando Sánchez-Lasheras; José Antonio Vega
Journal:  Dental Press J Orthod       Date:  2015-10

5.  Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment.

Authors:  V Venkataramana; S Sathesh Kumar; B Vishnuvardhan Reddy; A Sreekanth Cherukuri; K Raja Sigamani; G Chandrasekhar
Journal:  J Pharm Bioallied Sci       Date:  2014-07

6.  A Novel Method to Quantify Longitudinal Orthodontic Bone Changes with In Vivo Micro-CT Data.

Authors:  Chao Wang; Li Cao; Chongshi Yang; Yubo Fan
Journal:  J Healthc Eng       Date:  2018-10-01       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.